Definium Therapeutics, Inc. (DFTX) Misses Q1 EPS by 23c

Definium Therapeutics, Inc. (NASDAQ: DFTX) reported Q1 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Definium Therapeutics, Inc. (DFTX) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• Grocery Outlet Holding (GO) PT Raised to $11.50 at UBS
• Dillard's Inc. (DDS) PT Raised to $468 at UBS